Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) Net Margin: 2019-2025

Historic Net Margin for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -4,849.16%.

  • CureVac N.V's Net Margin fell 436466.00% to -4,849.16% in Q2 2025 from the same period last year, while for Jun 2025 it was 37.79%, marking a year-over-year increase of 45438.00%. This contributed to the annual value of 30.30% for FY2024, which is 51426.00% up from last year.
  • Latest data reveals that CureVac N.V reported Net Margin of -4,849.16% as of Q2 2025, which was up 15.47% from -5,736.39% recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Net Margin registered a high of 1,180,978.11% during Q2 2021, and its lowest value of -991,146.98% during Q4 2021.
  • Moreover, its 3-year median value for Net Margin was -630.59% (2024), whereas its average is -1,462.28%.
  • Examining YoY changes over the last 5 years, CureVac N.V's Net Margin showed a top increase of 99,004,900bps in 2022 and a maximum decrease of 118,126,381bps in 2022.
  • Over the past 5 years, CureVac N.V's Net Margin (Quarterly) stood at -991,146.98% in 2021, then spiked by 99,004,900bps to -1,097.98% in 2022, then spiked by 71,427bps to -383.71% in 2023, then slumped by 31,803bps to -701.74% in 2024, then tumbled by 436,466bps to -4,849.16% in 2025.
  • Its Net Margin was -4,849.16% in Q2 2025, compared to -5,736.39% in Q1 2025 and -701.74% in Q4 2024.